Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies

Twist Bioscience Corporation (Nasdaq: TWST) today announced preclinical data for three of its proprietary antibodies against the S1 protein in SARS-CoV-2, the virus that causes COVID-19.